Markets

Insider Trading

Hedge Funds

Retirement

Opinion

30 Countries with the Highest Depression Rates

In this piece, we will take a look at 30 countries with the highest depression rates. For more countries, head on over to 5 Countries with the Highest Depression Rates.

Despite humankind’s technological progress, the age-old question of whether money buys happiness is still often on everyone’s minds. This query pops up more during times of economic turmoil such as last year when inflation soared to a record high. And its answer depends on who you ask. For instance, most people who struggle with their monthly bills will give a strong and resounding ‘yes’, while others, such as the billionaire Warren Buffett of Berkshire Hathaway Inc. (NYSE:BRK-A), believe that there is more to life than money, with the greatest sources of pleasure for Mr. Buffett being the satisfaction that he finds in his work and spending time with his loved ones.

Additionally, advances in modern day medical science have allowed humans to categorize and treat more diseases than previously thought. One of the newer fields of today’s medicine is depression and mental health disorders. While the term depression was coined in the 14th century, the earliest theories studying the cause of the disease were more philosophical in nature. In fact, it wasn’t until the mid 1900s that researchers were able to determine that depression is caused by imbalances of neurotransmitters in the brain. The most common neurotransmitter that is related to depression is serotonin and medications to fight the disease often work by trying to increase its level in the brain.

Anxiety and Depression Treatment Industry

Estimates from the World Health Organization (WHO) suggest that at least 280 million people suffer from depression all over the world. Women are far more likely to be depressed than men, and depression truly is a deadly disease as it can also lead to a loss of life through suicide. The huge number of depression patients also opens up a large market for treatments. According to research from Emergen Research, the global anxiety and depression treatment market was worth $12.06 billion in 2019 and is set to grow through a compounded annual growth rate (CAGR) of 3.9% between then and 2027 to sit at an estimated $16 billion by the end of the forecast period. The research firm believes that the market will grow due to higher diagnosis and testing as well as people who currently use medicines to develop a tolerance for them. Additionally, it also outlines that within the market, antidepressants held the highest share, as they commanded 63.9% of all sales in 2019.

The Diagnostic and Statistical Manual of Mental Disorders Text Revision (DSM-V TR), which is sort of a handbook for mental health practitioners in America, lists down different kinds of depression such as major depressive disorder, persistent depression (dysthymia), and bipolar disorder. Another pesky form of depression, that doctors are just starting to battle, is treatment-resistant depression. As the name suggests, this kind of illness often does not respond to treatments, and unsurprisingly, the market for treatments for this particular illness is set to grow faster than the broader industry for depression treatments. At least that’s what a research report from Fortune Business Insights would have you believe as it estimates that the treatment market for resistant depression will grow at a CAGR of 9% between 2022 and 2029 and nearly double from its initial value of $1.55 billion in 2022 to sit at $2.83 billion by 2029.

However, medications are not the only treatments for depression, despite being the most popular ones. Other options include cognitive behavioral therapy, which involves changing behavior patterns and brain simulation through electricity. At the same time, medication for depression is also seeing a bit of a revolutionary change these days, with the Food and Drug Administration (FDA) approving the first new treatment of depression in decades in 2019 when it approved esketamine (sold as Spravato by a Johnson & Johnson (NYSE:JNJ) subsidiary) as a treatment of depression. This trend of new drugs continued in 2022, when Dextromethorphan/bupropion (sold as Auvelity) was also approved.

Sharing the progress that Auvelity has made so far, the drug’s manufacturer, Axsome Therapeutics, Inc. (NASDAQ:AXSM), outlined during its fourth quarter earnings call:

We launched Auvelity on October 19 and despite launching in Q4, a traditionally challenging quarter due to multiple holidays. We saw early signs of encouraging uptake with our initial HCP adopters. With only a tangible lease of promotion in Q4, 2,200 unique HCPs for prescriptions for over 6,000 new patients. Those metrics have grown to 4,300 unique HCP writers and over 13,700 new patients since launch. Importantly, HCPs who have written ability are gaining critical early clinical experience and are reporting promising patient response that is consistent with that — with what we saw in clinical trials with many reporting that we’re seeing rapid onset of action and rapid achievement of remission. With regards to payer coverage, the commercial channel is expected to be the primary channel for Auvelity as it accounts for more than 60% of antidepressant prescription item.

Interactions with commercial payers as it relates to Auvelity have been active and productive. Effective January 2023, we have contracted with one of the largest group purchasing organizations, or GPO’s, for potential coverage of Auvelity. As a result, pharmacy benefit managers or PBMs and health plans under this GPO will now be able to make formulary coverage decisions for Auvelity based on the contracted terms. These interactions with commercial payers are proceeding as expected during the standard six to nine month period post-launch when new drugs are blocked, while coverage decisions are being made. In the non-commercial channel, Medicaid coverage became effective in 49 states on January 1, and Medicare plans have up to six months post-launch to determine coverage and add Auvelity to formulary.

With these details in mind, let’s take a look at countries with the highest rate of depression.

Our Methodology

For our list of countries with the highest depression rates, we used data from the University of Washington and the Bill & Melinda Gates foundation’s Institute for Health Metrics and Evaluation to rank all countries in the world according to rates of major depressive disorders. Out of these, the top thirty countries with the highest rates of depression are listed below.

30 Countries with the Highest Depression Rates

30. State of Qatar

Depression In Percentage of Population: 4.92%

The State of Qatar is a Western Asian country that is one of the most prosperous nations in the world with a GDP per capita of $113,875. Despite this, it ranks among the top thirty countries in the world with high depression rates.

29. United States of America

Depression In Percentage of Population: 4.92%

The United States of America is another rich country, with the world’s largest economy. But still, it has high depression rates.

28. Republic of Cuba

Depression In Percentage of Population: 4.95%

The Republic of Cuba is an island nation in the Caribbean Sea with a low nominal GDP per capita of less than $10,000.

27. Kingdom of Sweden

Depression In Percentage of Population: 4.98%

The Kingdom of Sweden is a prosperous Nordic country that is one of the few first world countries in the world.

26. Republic of Ireland

Depression In Percentage of Population: 4.99%

The Republic of Ireland is one of the richest countries in the world in terms of per capita income.

25. Republic of Finland

Depression In Percentage of Population: 5.00%

The Republic of Finland is another developed European nation.

24. State of Libya

Depression In Percentage of Population: 5.01%

The State of Libya is an African country that has seen significant conflict in recent years.

23. United Kingdom of Great Britain and Northern Ireland

Depression In Percentage of Population: 5.02%

The U.K. is another highly developed nation and a global power player. Despite its riches, it is still one country with high depression rates.

22. Republic of Belarus

Depression In Percentage of Population: 5.04%

The Republic of Belarus is a landlocked Northern European state with a relatively low per capita income.

21. Commonwealth of Australia

Depression In Percentage of Population: 5.05%

The Commonwealth of Australia is an Oceanic country and a developed nation.

20. Republic of Lebanon

Depression In Percentage of Population: 5.09%

The Republic of Lebanon is a Western Asian country that has faced significant economic turmoil of late as its currency crashed and banks freeze account balances.

19. Republic of Estonia

Depression In Percentage of Population: 5.09%

The Republic of Estonia is a Western European country.

18. Republic of San Marino

Depression In Percentage of Population: 5.09%

The Republic of San Marino is one of the smallest countries in the world with no water and 61 km squared in area.

17. Republic of Suriname

Depression In Percentage of Population: 5.10%

The Republic of Suriname is a South American country with a coast to the Atlantic Ocean.

16. Gabonese Republic

Depression In Percentage of Population: 5.12%

The Gabonese Republic is a Central African country with a $39 billion economy.

15. Co‑operative Republic of Guyana

Depression In Percentage of Population: 5.15%

The Co‑operative Republic of Guyana is a relatively prosperous nation with a PPP adjusted GDP per capita of $60,648. Despite this, it has high rates of depression.

14. Republic of Latvia

Depression In Percentage of Population: 5.16%

The Republic of Latvia is a Baltic European country with a lower income but a higher depression rate than Guyana.

13. Kingdom of Lesotho

Depression In Percentage of Population: 5.17%

The Kingdom of Lesotho is a landlocked South African country with a low per capita income of $1,187.

12. Principality of Monaco

Percentage of Population: 5.21%

The Principality of Monaco is one of the smallest countries in the world which covers just 2.02 kilometers squared in area. It has the second highest nominal income in the world. Yet, it has high rates of depression as well

11. Ukraine

Depression In Percentage of Population: 5.25%

Ukraine is the second largest country in Europe in terms of land mass.

10. Republic of Lithuania

Depression In Percentage of Population: 5.42%

The Republic of Lithuania is a Baltic European country with a high PPP per capita income of $47,107.

9. Islamic Republic of Iran

Depression In Percentage of Population: 5.48%

Iran is an Asian country that has seen significant turmoil and an unfriendly government over the years, perhaps explaining why it is a country with a high depression rate.

8. Kingdom of Morocco

Depression In Percentage of Population: 5.49%

The Kingdom of Morocco is an African country with a low GDP per capita of $9,808.

7. Kingdom of Bahrain

 Depression In Percentage of Population: 5.52%

The Kingdom of Bahrain is a Western Asian island country made of dozens of natural and artificial islands.

6. Republic of Tunisia

Depression In Percentage of Population: 5.75%

The Republic of Tunisia is an African country which is a rare one with high human development levels on the continent. Despite this, it also ranks high on our list of countries with high depression rates.

Click to continue reading and see 5 Countries with the Highest Depression Rates.

Suggested Articles:

Disclosure: None. 30 Countries with the Highest Depression Rates is originally published on Insider Monkey.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99 a month.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!